Metformin: From Mechanisms of Action to Therapies
Tóm tắt
Từ khóa
Tài liệu tham khảo
Algire, 2011, Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo, Oncogene, 30, 1174, 10.1038/onc.2010.483
2014, Standards of medical care in diabetes—2014, Diabetes Care, 37, S14
Andrzejewski, 2014, Metformin directly acts on mitochondria to alter cellular bioenergetics, Cancer Metab., 2, 10.1186/2049-3002-2-12
Bai, 2013, Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts, PLoS ONE, 8, e72120, 10.1371/journal.pone.0072120
Balteau, 2011, NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1, Cardiovasc. Res., 92, 237, 10.1093/cvr/cvr230
Balteau, 2014, AMPK activation by glucagon-like peptide-1 prevents NADPH oxidase activation induced by hyperglycemia in adult cardiomyocytes, Am. J. Physiol. Heart Circ. Physiol., 10.1152/ajpheart.00210.2014
Batandier, 2006, The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin, J. Bioenerg. Biomembr., 38, 33, 10.1007/s10863-006-9003-8
Batchuluun, 2014, Metformin and liraglutide ameliorate high glucose-induced oxidative stress via inhibition of PKC-NAD(P)H oxidase pathway in human aortic endothelial cells, Atherosclerosis, 232, 156, 10.1016/j.atherosclerosis.2013.10.025
Becker, 2009, Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study, Diabetes, 58, 745, 10.2337/db08-1028
Ben Sahra, 2010, Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells, Cancer Res., 70, 2465, 10.1158/0008-5472.CAN-09-2782
Bertrand, 2006, AMPK activation restores the stimulation of glucose uptake in an in vitro model of insulin-resistant cardiomyocytes via the activation of protein kinase B, Am. J. Physiol. Heart Circ. Physiol., 291, H239, 10.1152/ajpheart.01269.2005
Bhamra, 2008, Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening, Basic Res. Cardiol., 103, 274, 10.1007/s00395-007-0691-y
Bhatt, 2013, C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes, Diabetes, 62, 3851, 10.2337/db13-0039
Birsoy, 2014, Metabolic determinants of cancer cell sensitivity to glucose limitation and biguanides, Nature, 508, 108, 10.1038/nature13110
Boussageon, 2012, Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials, PLoS Med., 9, e1001204, 10.1371/journal.pmed.1001204
Bridges, 2014, Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria, Biochem. J., 462, 475, 10.1042/BJ20140620
Brunmair, 2004, Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions?, Diabetes, 53, 1052, 10.2337/diabetes.53.4.1052
Bugger, 2014, Molecular mechanisms of diabetic cardiomyopathy, Diabetologia, 57, 660, 10.1007/s00125-014-3171-6
Buzzai, 2007, Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth, Cancer Res., 67, 6745, 10.1158/0008-5472.CAN-06-4447
Cabreiro, 2013, Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism, Cell, 153, 228, 10.1016/j.cell.2013.02.035
Cao, 2014, Low Concentrations of Metformin Suppress Glucose Production in Hepatocytes through AMP-activated Protein Kinase (AMPK), J. Biol. Chem., 289, 20435, 10.1074/jbc.M114.567271
Caton, 2010, Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5, J. Endocrinol., 205, 97, 10.1677/JOE-09-0345
Cheang, 2014, Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5′ adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor δ pathway, Arterioscler. Thromb. Vasc. Biol., 34, 830, 10.1161/ATVBAHA.113.301938
De Jager, 2005, Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial, J. Intern. Med., 257, 100, 10.1111/j.1365-2796.2004.01420.x
Detaille, 2005, Metformin prevents high-glucose-induced endothelial cell death through a mitochondrial permeability transition-dependent process, Diabetes, 54, 2179, 10.2337/diabetes.54.7.2179
Drahota, 2014, Biguanides inhibit complex I, II and IV of rat liver mitochondria and modify their functional properties, Physiol. Res., 63, 1, 10.33549/physiolres.932600
Dykens, 2008, Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro, Toxicol. Appl. Pharmacol., 233, 203, 10.1016/j.taap.2008.08.013
El-Mir, 2000, Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I, J. Biol. Chem., 275, 223, 10.1074/jbc.275.1.223
El-Mir, 2008, Neuroprotective role of antidiabetic drug metformin against apoptotic cell death in primary cortical neurons, J. Mol. Neurosci., 34, 77, 10.1007/s12031-007-9002-1
Eurich, 2013, Comparative safety and effectiveness of metformin in patients with diabetes mellitus and heart failure: systematic review of observational studies involving 34,000 patients, Circ. Heart Fail., 6, 395, 10.1161/CIRCHEARTFAILURE.112.000162
Evans, 2005, Metformin and reduced risk of cancer in diabetic patients, BMJ, 330, 1304, 10.1136/bmj.38415.708634.F7
Faubert, 2013, AMPK is a negative regulator of the Warburg effect and suppresses tumor growth in vivo, Cell Metab., 17, 113, 10.1016/j.cmet.2012.12.001
Foretz, 2010, Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state, J. Clin. Invest., 120, 2355, 10.1172/JCI40671
Fullerton, 2013, Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin, Nat. Med., 19, 1649, 10.1038/nm.3372
Gandini, 2014, Metformin and cancer risk and mortality: A systematic review and meta-analysis taking into account biases and confounders, Cancer Prev. Res. (Phila)., 7, 867, 10.1158/1940-6207.CAPR-13-0424
Geerling, 2014, Metformin lowers plasma triglycerides by promoting VLDL-triglyceride clearance by brown adipose tissue in mice, Diabetes, 63, 880, 10.2337/db13-0194
Ginion, 2011, Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake, Am. J. Physiol. Heart Circ. Physiol., 301, H469, 10.1152/ajpheart.00986.2010
Gong, 2012, Metformin pathways: pharmacokinetics and pharmacodynamics, Pharmacogenet. Genomics, 22, 820, 10.1097/FPC.0b013e3283559b22
Gontier, 2008, High and typical 18F-FDG bowel uptake in patients treated with metformin, Eur. J. Nucl. Med. Mol. Imaging, 35, 95, 10.1007/s00259-007-0563-6
Grassian, 2014, IDH1 mutations alter citric acid cycle metabolism and increase dependence on oxidative mitochondrial metabolism, Cancer Res., 74, 3317, 10.1158/0008-5472.CAN-14-0772-T
Grundy, 1999, Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association, Circulation, 100, 1134, 10.1161/01.CIR.100.10.1134
Guigas, 2004, Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study, Biochem. J., 382, 877, 10.1042/BJ20040885
Gundewar, 2009, Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure, Circ. Res., 104, 403, 10.1161/CIRCRESAHA.108.190918
Haq, 2013, Oncogenic BRAF regulates oxidative metabolism via PGC1α and MITF, Cancer Cell, 23, 302, 10.1016/j.ccr.2013.02.003
Hawley, 2010, Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation, Cell Metab., 11, 554, 10.1016/j.cmet.2010.04.001
He, 2009, Metformin and insulin suppress hepatic gluconeogenesis through phosphorylation of CREB binding protein, Cell, 137, 635, 10.1016/j.cell.2009.03.016
He, 2013, Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes, Diabetes, 62, 1270, 10.2337/db12-0533
Hinke, 2007, Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic beta-cells through restoration of mitochondrial electron transfer, Br. J. Pharmacol., 150, 1031, 10.1038/sj.bjp.0707189
Hirsch, 2012, Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain, Endocrinology, 153, 4354, 10.1210/en.2012-1145
Hollunger, 1955, Guanidines and oxidative phosphorylations, Acta Pharmacol. Toxicol. (Copenh.), 11, 1, 10.1111/j.1600-0773.1955.tb02972.x
Holman, 2008, 10-year follow-up of intensive glucose control in type 2 diabetes, N. Engl. J. Med., 359, 1577, 10.1056/NEJMoa0806470
Hong, 2013, Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease, Diabetes Care, 36, 1304, 10.2337/dc12-0719
Horman, 2012, AMP-activated protein kinase in the control of cardiac metabolism and remodeling, Curr. Heart Fail. Rep., 9, 164, 10.1007/s11897-012-0102-z
Hosono, 2010, Metformin suppresses colorectal aberrant crypt foci in a short-term clinical trial, Cancer Prev. Res. (Phila.), 3, 1077, 10.1158/1940-6207.CAPR-10-0186
Huang, 2008, Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice, Biochem. J., 412, 211, 10.1042/BJ20080557
Jablonski, 2010, Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program, Diabetes, 59, 2672, 10.2337/db10-0543
Janzer, 2014, Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells, Proc. Natl. Acad. Sci. USA, 111, 10574, 10.1073/pnas.1409844111
Jeon, 2012, AMPK regulates NADPH homeostasis to promote tumour cell survival during energy stress, Nature, 485, 661, 10.1038/nature11066
Kim, 2013, Metformin-induced inhibition of the mitochondrial respiratory chain increases FGF21 expression via ATF4 activation, Biochem. Biophys. Res. Commun., 440, 76, 10.1016/j.bbrc.2013.09.026
Kukidome, 2006, Activation of AMP-activated protein kinase reduces hyperglycemia-induced mitochondrial reactive oxygen species production and promotes mitochondrial biogenesis in human umbilical vein endothelial cells, Diabetes, 55, 120, 10.2337/diabetes.55.01.06.db05-0943
Lamanna, 2011, Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials, Diabetes Obes. Metab., 13, 221, 10.1111/j.1463-1326.2010.01349.x
Lee, 2010, AMPK-dependent repression of hepatic gluconeogenesis via disruption of CREB.CRTC2 complex by orphan nuclear receptor small heterodimer partner, J. Biol. Chem., 285, 32182, 10.1074/jbc.M110.134890
Legtenberg, 2002, Metformin improves cardiac functional recovery after ischemia in rats, Horm. Metab. Res., 34, 182, 10.1055/s-2002-26705
Lexis, 2014, Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial, JAMA, 311, 1526, 10.1001/jama.2014.3315
Lin, 2000, Metformin reverses fatty liver disease in obese, leptin-deficient mice, Nat. Med., 6, 998, 10.1038/79697
Logie, 2012, Cellular responses to the metal-binding properties of metformin, Diabetes, 61, 1423, 10.2337/db11-0961
Madiraju, 2014, Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase, Nature, 510, 542, 10.1038/nature13270
Maida, 2011, Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice, Diabetologia, 54, 339, 10.1007/s00125-010-1937-z
Marchesini, 2001, Metformin in non-alcoholic steatohepatitis, Lancet, 358, 893, 10.1016/S0140-6736(01)06042-1
Margel, 2013, Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes, J. Clin. Oncol., 31, 3069, 10.1200/JCO.2012.46.7043
Masoudi, 2005, Thiazolidinediones, metformin, and outcomes in older patients with diabetes and heart failure: an observational study, Circulation, 111, 583, 10.1161/01.CIR.0000154542.13412.B1
Memmott, 2010, Metformin prevents tobacco carcinogen—induced lung tumorigenesis, Cancer Prev. Res. (Phila.), 3, 1066, 10.1158/1940-6207.CAPR-10-0055
Miller, 2013, Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP, Nature, 494, 256, 10.1038/nature11808
Moiseeva, 2013, Metformin inhibits the senescence-associated secretory phenotype by interfering with IKK/NF-κB activation, Aging Cell, 12, 489, 10.1111/acel.12075
Mulherin, 2011, Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell, Endocrinology, 152, 4610, 10.1210/en.2011-1485
Muller, 1997, Action of metformin on erythrocyte membrane fluidity in vitro and in vivo, Eur. J. Pharmacol., 337, 103, 10.1016/S0014-2999(97)01287-9
Narise, 2014, Optimization of biguanide derivatives as selective antitumor agents blocking adaptive stress responses in the tumor microenvironment, Drug Des. Devel. Ther., 8, 701
Natali, 2006, Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review, Diabetologia, 49, 434, 10.1007/s00125-006-0141-7
Noppe, 2014, Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1, J. Mol. Cell. Cardiol., 74, 32, 10.1016/j.yjmcc.2014.04.018
Ouslimani, 2005, Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells, Metabolism, 54, 829, 10.1016/j.metabol.2005.01.029
Ouslimani, 2007, Metformin reduces endothelial cell expression of both the receptor for advanced glycation end products and lectin-like oxidized receptor 1, Metabolism, 56, 308, 10.1016/j.metabol.2006.10.010
Owen, 2000, Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochem. J., 348, 607, 10.1042/bj3480607
Paiva, 2009, Metformin prevents myocardial reperfusion injury by activating the adenosine receptor, J. Cardiovasc. Pharmacol., 53, 373, 10.1097/FJC.0b013e31819fd4e7
Pearce, 2009, Enhancing CD8 T-cell memory by modulating fatty acid metabolism, Nature, 460, 103, 10.1038/nature08097
Piel, 2014, Metformin induces lactate production in peripheral blood mononuclear cells and platelets through specific mitochondrial complex I inhibition, Acta Physiol. (Oxf.)
Pollak, 2012, The insulin and insulin-like growth factor receptor family in neoplasia: an update, Nat. Rev. Cancer, 12, 159, 10.1038/nrc3215
Pollak, 2012, Investigating metformin for cancer prevention and treatment: the end of the beginning, Cancer Discov., 2, 778, 10.1158/2159-8290.CD-12-0263
Pollak, 2013, Potential applications for biguanides in oncology, J. Clin. Invest., 123, 3693, 10.1172/JCI67232
Pollak, 2013, Targeting oxidative phosphorylation: why, when, and how, Cancer Cell, 23, 263, 10.1016/j.ccr.2013.02.015
Pollak, 2014, Overcoming Drug Development Bottlenecks With Repurposing: Repurposing biguanides to target energy metabolism for cancer treatment, Nat. Med., 20, 591, 10.1038/nm.3596
Preiss, 2014, Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial, Lancet Diabetes Endocrinol., 2, 116, 10.1016/S2213-8587(13)70152-9
Samuel, 2009, Fasting hyperglycemia is not associated with increased expression of PEPCK or G6Pc in patients with Type 2 Diabetes, Proc. Natl. Acad. Sci. USA, 106, 12121, 10.1073/pnas.0812547106
Sasaki, 2009, Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase, Circulation, 119, 2568, 10.1161/CIRCULATIONAHA.108.798561
Scotland, 2013, Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells, Leukemia, 27, 2129, 10.1038/leu.2013.107
Shackelford, 2013, LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin, Cancer Cell, 23, 143, 10.1016/j.ccr.2012.12.008
Shaw, 2005, The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin, Science, 310, 1642, 10.1126/science.1120781
Shu, 2007, Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action, J. Clin. Invest., 117, 1422, 10.1172/JCI30558
Stephenne, 2011, Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status, Diabetologia, 54, 3101, 10.1007/s00125-011-2311-5
Suissa, 2014, Metformin and cancer: mounting evidence against an association, Diabetes Care, 37, 1786, 10.2337/dc14-0500
Timmermans, 2014, A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake, Am. J. Physiol. Heart Circ. Physiol., 306, H1619, 10.1152/ajpheart.00965.2013
Tsilidis, 2014, Metformin Does Not Affect Cancer Risk: A Cohort Study in the U.K. Clinical Practice Research Datalink Analyzed Like an Intention-to-Treat Trial, Diabetes Care, 37, 2522, 10.2337/dc14-0584
Tsuda, 2009, Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin, Mol. Pharmacol., 75, 1280, 10.1124/mol.109.056242
Tucker, 1981, Metformin kinetics in healthy subjects and in patients with diabetes mellitus, Br. J. Clin. Pharmacol., 12, 235, 10.1111/j.1365-2125.1981.tb01206.x
1998, Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34), Lancet, 352, 854, 10.1016/S0140-6736(98)07037-8
Viollet, 2012, Cellular and molecular mechanisms of metformin: an overview, Clin. Sci., 122, 253, 10.1042/CS20110386
Wheaton, 2014, Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis, Elife, 3, e02242, 10.7554/eLife.02242
Whittington, 2013, Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon, Cardiovasc. Drugs Ther., 27, 5, 10.1007/s10557-012-6425-x
Wilcock, 1994, Accumulation of metformin by tissues of the normal and diabetic mouse, Xenobiotica, 24, 49, 10.3109/00498259409043220
Woo, 2014, Metformin ameliorates hepatic steatosis and inflammation without altering adipose phenotype in diet-induced obesity, PLoS ONE, 9, e91111, 10.1371/journal.pone.0091111
Wu, 2014, The association of diabetes and anti-diabetic medications with clinical outcomes in multiple myeloma, Br. J. Cancer, 111, 628, 10.1038/bjc.2014.307
Xiao, 2010, Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway, Cardiovasc. Res., 87, 504, 10.1093/cvr/cvq066
Xie, 2011, Improvement of cardiac functions by chronic metformin treatment is associated with enhanced cardiac autophagy in diabetic OVE26 mice, Diabetes, 60, 1770, 10.2337/db10-0351
Xu, 2014, Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase α2, Hypertension, 63, 723, 10.1161/HYPERTENSIONAHA.113.02619
Yeh, 2010, AMP-activated protein kinase activation during cardioplegia-induced hypoxia/reoxygenation injury attenuates cardiomyocytic apoptosis via reduction of endoplasmic reticulum stress, Mediators Inflamm., 2010, 130636, 10.1155/2010/130636
Yin, 2011, Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure, Am. J. Physiol. Heart Circ. Physiol., 301, H459, 10.1152/ajpheart.00054.2011
Zakikhani, 2006, Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells, Cancer Res., 66, 10269, 10.1158/0008-5472.CAN-06-1500
Zang, 2004, AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells, J. Biol. Chem., 279, 47898, 10.1074/jbc.M408149200
Zhang, 2011, Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats, Clin. Exp. Pharmacol. Physiol., 38, 55, 10.1111/j.1440-1681.2010.05461.x
Zhou, 2001, Role of AMP-activated protein kinase in mechanism of metformin action, J. Clin. Invest., 108, 1167, 10.1172/JCI13505
Zhou, 2009, Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study, Diabetes, 58, 1434, 10.2337/db08-0896